Market Currents
NPS Pharmaceuticals (NPSP -34.9%) sinks after the company reports "adverse events" in a trial of...
-
Monday, October 31, 2011, 11:18 AM ETNPS Pharmaceuticals (NPSP -34.9%) sinks after the company reports "adverse events" in a trial of its experimental short bowel syndrome therapy - Gattex - including two patients dying from cancer.
Other date
Latest Articles
